Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma

Human Pathology

Volumn 45, Issue 2, 2014, Pages 352-358

  Hou, Jun ^a   Jiang, Dongxian ^a   Zhang, Jingchuan ^b   Gavine, Paul R ^b   Xu, Songtao ^a   Liu, Yalan ^a   Xu, Chen ^a   Huang, Jie ^a   Tan, Yunshan ^a   Wang, Hao ^a   Lu, Yachao ^b   Zheng, Li ^b   Hou, Yingyong ^a   Tan, Lijie ^a  

^a FUDAN UNIVERSITY   (China)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Esophageal squamous cell carcinoma; Mutation; PIK3CA gene

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN;

ADULT; ADVENTITIA; AGED; ARTICLE; BONE METASTASIS; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; CHINESE; DISEASE FREE SURVIVAL; DNA EXTRACTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; EXON; FEMALE; FOLLOW UP; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PIK3CA GENE; SEX DIFFERENCE; SUBMUCOSA; TUMOR INVASION; VERY ELDERLY;

ESOPHAGEAL SQUAMOUS CELL CARCINOMA; MUTATION; PIK3CA GENE;

CARCINOMA, SQUAMOUS CELL; CHINA; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84892783833     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.09.011     Document Type: Article

References (30)

1. Y. Samuels, Z. Wang, and A. Bardelli et al. High frequency of mutations of the PIK3CA gene in human cancers Science 304 2004 554
2. Y. Samuels, and V.E. Velculescu Oncogenic mutations of PIK3CA in human cancers Cell Cycle 3 2004 1221 1224
3. Y. Samuels, and K. Ericson Oncogenic PI3K and its role in cancer Curr Opin Oncol 18 2006 77 82
4. Y. Samuels, and L.A. Diaz Jr. et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells Cancer Cell 7 2005 561 573
5. Y. Samuels, and T. Waldman Oncogenic mutations of PIK3CA in human cancers Curr Top Microbiol Immunol 347 2010 21 41
6. L. Zhao, and P.K. Vogt Class I PI3K in oncogenic cellular transformation Oncogene 27 2008 5486 5496
7. X. Liao, T. Morikawa, and P. Lochhead et al. Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review Clin Cancer Res 18 2012 2257 2268
8. E. Razis, M. Bobos, and V. Kotoula et al. Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer Breast Cancer Res Treat 128 2011 447 456
9. B. Konopka, A. Janiec-Jankowska, and E. Kwiatkowska et al. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors Hum Pathol 42 2011 1710 1719
10. J.J. Wallin, K.A. Edgar, and J. Guan et al. Gdc-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway Mol Cancer Ther 10 2011 2426 2436
11. R.C. Stein, and M.D. Waterfield PI3-kinase inhibition: a target for drug development? Mol Med Today 6 2000 347 357
12. J. Yuan, P.P. Mehta, and M.J. Yin et al. Pf-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity Mol Cancer Ther 10 2011 2189 2199
13. S.M. Brachmann, I. Hofmann, and C. Schnell et al. Specific apoptosis induction by the dual PI3K/mTOR inhibitor nvp-bez235 in HER2 amplified and PIK3CA mutant breast cancer cells Proc Natl Acad Sci U S A 106 2009 22299 22304
14. E. Montgomery, J.K. Field, P. Boffetta, Y. Daigo, M. Shimizu, and T. Shimoda Squamous cell carcinoma of the oesophagus F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO Classification of Tumours of the Digestive System 4th ed. 2010 IARC Press Lyon 18 24
15. A. Pennathur, M.K. Gibson, B.A. Jobe, and J.D. Luketich Oesophageal carcinoma Lancet 381 2013 400 412
16. W.A. Phillips, S.E. Russell, and M.L. Ciavarella et al. Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus Int J Cancer 118 2006 2644 2646
17. R. Mori, H. Ishiguro, and M. Kimura et al. PIK3CA mutation status in Japanese esophageal squamous cell carcinoma J Surg Res 145 2008 320 326
18. I. Akagi, M. Miyashita, and H. Makino et al. Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma Int J Oncol 34 2009 767 775
19. H. Shigaki, Y. Baba, and M. Watanabe et al. PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma Clin Cancer Res 19 2013 2451 2459
20. J.T. Kaifi, N.J. Gusani, and Y. Jiang et al. Multidisciplinary management of early and locally advanced esophageal cancer J Clin Gastroenterol 45 2011 391 399
21. S. Wu, Z. Zhu, J. He, X. Luo, J. Xu, and L. Ren-Heidenreich A novel mutant-enriched liquid chip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples Clin Chem Lab Med 48 2010 1103 1106
22. S. Benvenuti, M. Frattini, and S. Arena et al. PIK3CA cancer mutations display gender and tissue specificity patterns Hum Mutat 29 2008 284 288
23. K.E. Bachman, P. Argani, and Y. Samuels et al. The PIK3CA gene is mutated with high frequency in human breast cancers Cancer Biol Ther 3 2004 772 775
24. J.W. Lee, Y.H. Soung, and S.Y. Kim et al. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas Oncogene 24 2005 1477 1480
25. L.H. Saal, K. Holm, and M. Maurer et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and Erbb2, and are mutually exclusive with PTEN loss in human breast carcinoma Cancer Res 65 2005 2554 2559
26. D.K. Broderick, C. Di, and T.J. Parrett et al. Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas Cancer Res 64 2004 5048 5050
27. S. Loi, B. Haibe-Kains, and S. Majjaj et al. PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer Proc Natl Acad Sci U S A 107 2009 10208 10213
28. A. Abe, T. Minaguchi, and H. Ochi et al. PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma Hum Pathol 44 2013 199 207
29. V. Eklof, M.L. Wikberg, and S. Edin et al. The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer Br J Cancer 108 2013 2153 2163
30. C.H. Maeng, J. Lee, and P. van Hummelen et al. High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations PLoS One 7 2012 e41655